P ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNOTE-756 & BEGONIA" By Insights from 2023 ESMO Annual Meeting FEATURING Paolo Tarantino November 3, 2023 Comments 2 Login to view comments. Click here to Login Featured Video 03:15 Lilly Medical Affairs Unmet Needs...
8. Surgery Choices for Breast Cancer 9. Breast Reconstruction 10. Breast Cancer - Treatments & Side Effects 11. Survivorship After Treatment 12. Male Breast cancer 13. COVID-19 Impact on Breast Cancer 14. Gynecology 15. Obstetrician & Midwifery 16. Breast Cancer Prevention 17. Breast Cancer Aw...
标题:Association of tumor-infiltrating lymphocytes (TILs) with Recurrence Score (RS) in patients with hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (BC) - a translational analysis of four prospective multicentric studies. 报告人:Federica Miglietta (Padova, Italy) 时间:1...
Early breast cancer Adjuvant therapy Immunotherapy Radiation therapy Survivorship 1. Introduction 2023 was marked by long-awaited research results that directly influence early breast cancer management. Several studies shared a common objective of tailoring treatment intensity according to individual risk. In...
Breast cancer (BC) is one of the major public health challenges worldwide. Studies that address the new evidence on trends of BC are of great importance for preventing and controlling the occurrence and development of diseases and improving health. The a
Breast Cancer Research is the highest ranking breast cancer-specific title in the top quartile of oncology journals worldwide. Primarily publishing original ...
Exposure-efficacy and safety analysis of trastuzumab deruxtecan (T-DXd) in patients with advanced/metastatic HER2+ breast cancer (BC): Analyses from Phase 3 Studies DESTINY-Breast02 (DB-02) and DESTINY-Breast03 (DB-03). T-DXd在晚期/转移性HER2阳性乳腺癌患者中的暴露有效性和安全性:来自3期研...
Infectious agents are the third highest human cancer risk factor and may have a greater role in the origin and/or progression of cancers and related pathogenesis. Thus, knowing the specific viruses and microbial agents associated with a cancer type may p
Dec 1, 2023 Virginia Kaklamani, MD, GuestRobert A. Figlin, MD, FACP, HostStudies involving high-risk, early-stage, ER-positive breast cancer are among the most eagerly anticipated at this year’s San Antonio Breast Cancer Symposium (SABCS), to be held Dec. 5-9. Virginia Kaklam...
breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II ...